Janux Therapeutics (JANX) announced the promotion of Dr. Zachariah McIver to Chief Medical Officer. Dr. McIver joined Janux after serving as Amgen’s (AMGN) Executive Medical Director for over 4 years, leading cross-functional teams in the design, implementation, and execution of clinical and correlative study strategies.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JANX:
- Opco lists five potential biotech targets into JPMorgan conference
- Janux Therapeutics CEO sells $1.4M in common stock
- Janux Therapeutics 5.32M share Secondary priced at $63.00
- Salesforce up after Q3, GM outlines $5B in China business charges: Morning Buzz
- Janux Therapeutics announces $300M common stock offering